Suppr超能文献

丙型肝炎病毒感染的流行病学、传播、诊断及转归

Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection.

作者信息

Moosavy Seyed Hamid, Davoodian Parivash, Nazarnezhad Mirza Ali, Nejatizaheh Abdolazim, Eftekhar Ebrahim, Mahboobi Hamidreza

机构信息

M.D., Gastroenterologist and Hepatologist, Associate Professor, Department of Internal Medicine, Infectious and Tropical Disease Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Hormozgan, Iran.

M.D., Infectionist, Associate Professor, Infectious and Tropical Disease Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Hormozgan, Iran.

出版信息

Electron Physician. 2017 Oct 25;9(10):5646-5656. doi: 10.19082/5646. eCollection 2017 Oct.

Abstract

Hepatitis C infection is one of the main causes of chronic liver disorders worldwide. Nearly three percent (3%) of the world population has an HCV infection. Prevalence of HCV infection was higher in some groups such as injected drug users (IDUs) and HIV positive populations. Acute hepatitis has proven asymptomatic in most cases, and delay of diagnosis might lead to late onset of hepatocellular carcinoma and cirrhosis. Some host characteristics such as age, gender, body mass index, and viral properties are associated with HCV outcome hepatitis. Although disease progression is typically slow, some risk factors such as alcohol abuse and coinfection of patients with HBV and HIV can worsen the disease. On the other hand, viral overload is one of the main causes of prediction of HCV infection outcome. Prevalence of HCV infection will increase if we do not consider means of transmission, virus behaviors, and immunologic responses. Rapid diagnostic tests can help us to create preventive strategies among undeveloped villages and prisoners. Screening and training of the high-risk population such as IV drug users, dialysis patients, and hemophiliacs must be one of main HCV preventive programs. The present review is intended to help health policymakers to design suitable preventive and management programs.

摘要

丙型肝炎感染是全球慢性肝脏疾病的主要病因之一。全球近3%的人口感染了丙肝病毒(HCV)。在一些群体中,如注射吸毒者(IDU)和艾滋病毒阳性人群,HCV感染的患病率更高。在大多数情况下,急性肝炎已被证明是无症状的,诊断延迟可能导致肝细胞癌和肝硬化的晚期发病。一些宿主特征,如年龄、性别、体重指数和病毒特性与丙型肝炎的预后有关。虽然疾病进展通常缓慢,但一些危险因素,如酗酒以及患者同时感染乙肝病毒和艾滋病毒,会使病情恶化。另一方面,病毒载量是预测HCV感染结果的主要原因之一。如果我们不考虑传播途径、病毒行为和免疫反应,HCV感染的患病率将会增加。快速诊断测试可以帮助我们在不发达的村庄和囚犯中制定预防策略。对高危人群,如静脉吸毒者、透析患者和血友病患者进行筛查和培训,必须是主要的丙肝预防项目之一。本综述旨在帮助卫生政策制定者设计合适的预防和管理项目。

相似文献

1
Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection.
Electron Physician. 2017 Oct 25;9(10):5646-5656. doi: 10.19082/5646. eCollection 2017 Oct.
2
NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements. 2002;19(3):1-46.
3
Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
Adv Parasitol. 2016;91:111-231. doi: 10.1016/bs.apar.2015.12.003. Epub 2016 Feb 5.
4
Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.
Clin Liver Dis. 2003 Feb;7(1):261-87. doi: 10.1016/s1089-3261(02)00078-8.
5
Viral hepatitis and HIV infection among injection drug users in a central Iranian City.
J Addict Med. 2012 Dec;6(4):292-6. doi: 10.1097/ADM.0b013e3182659928.

引用本文的文献

4
Cellular Transformation by Human Cytomegalovirus.
Cancers (Basel). 2024 May 22;16(11):1970. doi: 10.3390/cancers16111970.
5
Advanced Theranostic Strategies for Viral Hepatitis Using Carbon Nanostructures.
Micromachines (Basel). 2023 Jun 1;14(6):1185. doi: 10.3390/mi14061185.
7
Knowledge of and Testing Rate for Hepatitis C Infection among the General Public of Saudi Arabia: A Cross-Sectional Study.
Int J Environ Res Public Health. 2023 Jan 23;20(3):2080. doi: 10.3390/ijerph20032080.
9
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate.
Proc Natl Acad Sci U S A. 2022 Mar 15;119(11):e2112008119. doi: 10.1073/pnas.2112008119. Epub 2022 Mar 9.
10
Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders.
Brain Sci. 2021 Nov 27;11(12):1569. doi: 10.3390/brainsci11121569.

本文引用的文献

2
Global epidemiology and genotype distribution of the hepatitis C virus infection.
J Hepatol. 2014 Nov;61(1 Suppl):S45-57. doi: 10.1016/j.jhep.2014.07.027. Epub 2014 Jul 30.
3
Global distribution and prevalence of hepatitis C virus genotypes.
Hepatology. 2015 Jan;61(1):77-87. doi: 10.1002/hep.27259. Epub 2014 Jul 28.
4
Vertical transmission of hepatitis C virus: systematic review and meta-analysis.
Clin Infect Dis. 2014 Sep 15;59(6):765-73. doi: 10.1093/cid/ciu447. Epub 2014 Jun 13.
5
Current management of hepatocellular carcinoma.
Gastroenterol Hepatol (N Y). 2014 Mar;10(3):153-61.
6
Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
World J Gastroenterol. 2014 Apr 21;20(15):4115-27. doi: 10.3748/wjg.v20.i15.4115.
7
Peripheral blood mononuclear cells microRNA predicts treatment outcome of hepatitis C virus genotype 1 infection.
Antiviral Res. 2014 May;105:135-42. doi: 10.1016/j.antiviral.2014.03.003. Epub 2014 Mar 15.
8
Distribution of hepatitis C virus genotypes among patients with hepatitis C virus infection in hormozgan, iran.
Hepat Mon. 2013 Dec 16;13(12):e14324. doi: 10.5812/hepatmon.14324. eCollection 2013.
9
Frequency of HCV infection in different dermatological disorders.
J Ayub Med Coll Abbottabad. 2012 Apr-Jun;24(2):58-61.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验